GUO Huimei, HUA Luoming, XUE Hua, WANG Jing, ZHAO Songying, ZHANG Jiangbo. Ruxolitinib for CALR-positive Myelofibrosis: A Case Report and Literature Review[J]. Cancer Research on Prevention and Treatment, 2018, 45(8): 612-614. DOI: 10.3971/j.issn.1000-8578.2018.17.1621
|
Citation:
|
GUO Huimei, HUA Luoming, XUE Hua, WANG Jing, ZHAO Songying, ZHANG Jiangbo. Ruxolitinib for CALR-positive Myelofibrosis: A Case Report and Literature Review[J]. Cancer Research on Prevention and Treatment, 2018, 45(8): 612-614. DOI: 10.3971/j.issn.1000-8578.2018.17.1621
|
GUO Huimei, HUA Luoming, XUE Hua, WANG Jing, ZHAO Songying, ZHANG Jiangbo. Ruxolitinib for CALR-positive Myelofibrosis: A Case Report and Literature Review[J]. Cancer Research on Prevention and Treatment, 2018, 45(8): 612-614. DOI: 10.3971/j.issn.1000-8578.2018.17.1621
|
Citation:
|
GUO Huimei, HUA Luoming, XUE Hua, WANG Jing, ZHAO Songying, ZHANG Jiangbo. Ruxolitinib for CALR-positive Myelofibrosis: A Case Report and Literature Review[J]. Cancer Research on Prevention and Treatment, 2018, 45(8): 612-614. DOI: 10.3971/j.issn.1000-8578.2018.17.1621
|
DownLoad: